0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and Japan Sickle Cell Disease Treatment Market Size, Status and Forecast 2021-2027
Published Date: September 2021
|
Report Code: QYRE-Auto-5J6745
Home | Market Reports | Health | Health Conditions | Genetic Disorders
Global and Japan Sickle Cell Disease Treatment Market Size Status and Forecast 2021 2027

Global and Japan Sickle Cell Disease Treatment Market Size, Status and Forecast 2021-2027

Code: QYRE-Auto-5J6745
Report
September 2021
123 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Global Sickle Cell Disease Treatment Scope and Market Size
Sickle Cell Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sickle Cell Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

Sickle Cell Anemia
Sickle Beta Thalassemia
Sickle Hemoglobin C Disease

Segment by Application

Hospitals
Clinics
Others

BY REGION

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

BY COMPANY

AstraZeneca
Eli Lilly
Novartis
Pfizer
Baxter
Emmaus Life Sciences
Bluebird bio
Blood Therapeutics
Sangamo Therapeutics
Acceleron Pharma
Arena Pharmaceuticals
Alnylam Pharmaceuticals
Sanofi
CRISPR Therapeutics
Vertex Pharmaceuticals, Inc.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Sickle Cell Anemia
1.2.3 Sickle Beta Thalassemia
1.2.4 Sickle Hemoglobin C Disease
1.3 Market by Application
1.3.1 Global Sickle Cell Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Disease Treatment Market Perspective (2016-2027)
2.2 Sickle Cell Disease Treatment Growth Trends by Regions
2.2.1 Sickle Cell Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sickle Cell Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Sickle Cell Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Sickle Cell Disease Treatment Industry Dynamic
2.3.1 Sickle Cell Disease Treatment Market Trends
2.3.2 Sickle Cell Disease Treatment Market Drivers
2.3.3 Sickle Cell Disease Treatment Market Challenges
2.3.4 Sickle Cell Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sickle Cell Disease Treatment Players by Revenue
3.1.1 Global Top Sickle Cell Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Sickle Cell Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Sickle Cell Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sickle Cell Disease Treatment Revenue
3.4 Global Sickle Cell Disease Treatment Market Concentration Ratio
3.4.1 Global Sickle Cell Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Disease Treatment Revenue in 2020
3.5 Sickle Cell Disease Treatment Key Players Head office and Area Served
3.6 Key Players Sickle Cell Disease Treatment Product Solution and Service
3.7 Date of Enter into Sickle Cell Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle Cell Disease Treatment Breakdown Data by Type
4.1 Global Sickle Cell Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Sickle Cell Disease Treatment Forecasted Market Size by Type (2022-2027)
5 Sickle Cell Disease Treatment Breakdown Data by Application
5.1 Global Sickle Cell Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Sickle Cell Disease Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Sickle Cell Disease Treatment Market Size (2016-2027)
6.2 North America Sickle Cell Disease Treatment Market Size by Type
6.2.1 North America Sickle Cell Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Sickle Cell Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Sickle Cell Disease Treatment Market Size by Type (2016-2027)
6.3 North America Sickle Cell Disease Treatment Market Size by Application
6.3.1 North America Sickle Cell Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Sickle Cell Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Sickle Cell Disease Treatment Market Size by Application (2016-2027)
6.4 North America Sickle Cell Disease Treatment Market Size by Country
6.4.1 North America Sickle Cell Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Sickle Cell Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Sickle Cell Disease Treatment Market Size (2016-2027)
7.2 Europe Sickle Cell Disease Treatment Market Size by Type
7.2.1 Europe Sickle Cell Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Sickle Cell Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Sickle Cell Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Sickle Cell Disease Treatment Market Size by Application
7.3.1 Europe Sickle Cell Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Sickle Cell Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Sickle Cell Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Sickle Cell Disease Treatment Market Size by Country
7.4.1 Europe Sickle Cell Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Sickle Cell Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Sickle Cell Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Sickle Cell Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Sickle Cell Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sickle Cell Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sickle Cell Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Sickle Cell Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Sickle Cell Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Sickle Cell Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Sickle Cell Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Sickle Cell Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Sickle Cell Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sickle Cell Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Sickle Cell Disease Treatment Market Size (2016-2027)
9.2 Latin America Sickle Cell Disease Treatment Market Size by Type
9.2.1 Latin America Sickle Cell Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Sickle Cell Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Sickle Cell Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Sickle Cell Disease Treatment Market Size by Application
9.3.1 Latin America Sickle Cell Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Sickle Cell Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Sickle Cell Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Sickle Cell Disease Treatment Market Size by Country
9.4.1 Latin America Sickle Cell Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Sickle Cell Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sickle Cell Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Sickle Cell Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Sickle Cell Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sickle Cell Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sickle Cell Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Sickle Cell Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Sickle Cell Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Sickle Cell Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Sickle Cell Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Sickle Cell Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Sickle Cell Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sickle Cell Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Sickle Cell Disease Treatment Introduction
11.1.4 AstraZeneca Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Sickle Cell Disease Treatment Introduction
11.2.4 Eli Lilly Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Sickle Cell Disease Treatment Introduction
11.3.4 Novartis Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Sickle Cell Disease Treatment Introduction
11.4.4 Pfizer Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 Baxter
11.5.1 Baxter Company Details
11.5.2 Baxter Business Overview
11.5.3 Baxter Sickle Cell Disease Treatment Introduction
11.5.4 Baxter Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.5.5 Baxter Recent Development
11.6 Emmaus Life Sciences
11.6.1 Emmaus Life Sciences Company Details
11.6.2 Emmaus Life Sciences Business Overview
11.6.3 Emmaus Life Sciences Sickle Cell Disease Treatment Introduction
11.6.4 Emmaus Life Sciences Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.6.5 Emmaus Life Sciences Recent Development
11.7 Bluebird bio
11.7.1 Bluebird bio Company Details
11.7.2 Bluebird bio Business Overview
11.7.3 Bluebird bio Sickle Cell Disease Treatment Introduction
11.7.4 Bluebird bio Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.7.5 Bluebird bio Recent Development
11.8 Blood Therapeutics
11.8.1 Blood Therapeutics Company Details
11.8.2 Blood Therapeutics Business Overview
11.8.3 Blood Therapeutics Sickle Cell Disease Treatment Introduction
11.8.4 Blood Therapeutics Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.8.5 Blood Therapeutics Recent Development
11.9 Sangamo Therapeutics
11.9.1 Sangamo Therapeutics Company Details
11.9.2 Sangamo Therapeutics Business Overview
11.9.3 Sangamo Therapeutics Sickle Cell Disease Treatment Introduction
11.9.4 Sangamo Therapeutics Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.9.5 Sangamo Therapeutics Recent Development
11.10 Acceleron Pharma
11.10.1 Acceleron Pharma Company Details
11.10.2 Acceleron Pharma Business Overview
11.10.3 Acceleron Pharma Sickle Cell Disease Treatment Introduction
11.10.4 Acceleron Pharma Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.10.5 Acceleron Pharma Recent Development
11.11 Arena Pharmaceuticals
11.11.1 Arena Pharmaceuticals Company Details
11.11.2 Arena Pharmaceuticals Business Overview
11.11.3 Arena Pharmaceuticals Sickle Cell Disease Treatment Introduction
11.11.4 Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.11.5 Arena Pharmaceuticals Recent Development
11.12 Alnylam Pharmaceuticals
11.12.1 Alnylam Pharmaceuticals Company Details
11.12.2 Alnylam Pharmaceuticals Business Overview
11.12.3 Alnylam Pharmaceuticals Sickle Cell Disease Treatment Introduction
11.12.4 Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.12.5 Alnylam Pharmaceuticals Recent Development
11.13 Sanofi
11.13.1 Sanofi Company Details
11.13.2 Sanofi Business Overview
11.13.3 Sanofi Sickle Cell Disease Treatment Introduction
11.13.4 Sanofi Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.13.5 Sanofi Recent Development
11.14 CRISPR Therapeutics
11.14.1 CRISPR Therapeutics Company Details
11.14.2 CRISPR Therapeutics Business Overview
11.14.3 CRISPR Therapeutics Sickle Cell Disease Treatment Introduction
11.14.4 CRISPR Therapeutics Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.14.5 CRISPR Therapeutics Recent Development
11.15 Vertex Pharmaceuticals, Inc.
11.15.1 Vertex Pharmaceuticals, Inc. Company Details
11.15.2 Vertex Pharmaceuticals, Inc. Business Overview
11.15.3 Vertex Pharmaceuticals, Inc. Sickle Cell Disease Treatment Introduction
11.15.4 Vertex Pharmaceuticals, Inc. Revenue in Sickle Cell Disease Treatment Business (2016-2021)
11.15.5 Vertex Pharmaceuticals, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Sickle Cell Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Sickle Cell Anemia
    Table 3. Key Players of Sickle Beta Thalassemia
    Table 4. Key Players of Sickle Hemoglobin C Disease
    Table 5. Global Sickle Cell Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Sickle Cell Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Sickle Cell Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Sickle Cell Disease Treatment Market Share by Regions (2016-2021)
    Table 9. Global Sickle Cell Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Sickle Cell Disease Treatment Market Share by Regions (2022-2027)
    Table 11. Sickle Cell Disease Treatment Market Trends
    Table 12. Sickle Cell Disease Treatment Market Drivers
    Table 13. Sickle Cell Disease Treatment Market Challenges
    Table 14. Sickle Cell Disease Treatment Market Restraints
    Table 15. Global Sickle Cell Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Sickle Cell Disease Treatment Market Share by Players (2016-2021)
    Table 17. Global Top Sickle Cell Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell Disease Treatment as of 2020)
    Table 18. Ranking of Global Top Sickle Cell Disease Treatment Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Sickle Cell Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Sickle Cell Disease Treatment Product Solution and Service
    Table 22. Date of Enter into Sickle Cell Disease Treatment Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Sickle Cell Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2016-2021)
    Table 26. Global Sickle Cell Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Sickle Cell Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Sickle Cell Disease Treatment Revenue Market Share by Application (2016-2021)
    Table 30. Global Sickle Cell Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Sickle Cell Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Sickle Cell Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Sickle Cell Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Sickle Cell Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Sickle Cell Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Sickle Cell Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 37. North America Sickle Cell Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 38. Europe Sickle Cell Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Sickle Cell Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Sickle Cell Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Sickle Cell Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Sickle Cell Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 43. Europe Sickle Cell Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 44. Asia-Pacific Sickle Cell Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Sickle Cell Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Sickle Cell Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Sickle Cell Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Sickle Cell Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
    Table 49. Asia-Pacific Sickle Cell Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
    Table 50. Latin America Sickle Cell Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Sickle Cell Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Sickle Cell Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Sickle Cell Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Sickle Cell Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 55. Latin America Sickle Cell Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 56. Middle East & Africa Sickle Cell Disease Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Sickle Cell Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Sickle Cell Disease Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Sickle Cell Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Sickle Cell Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
    Table 61. Middle East & Africa Sickle Cell Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
    Table 62. AstraZeneca Company Details
    Table 63. AstraZeneca Business Overview
    Table 64. AstraZeneca Sickle Cell Disease Treatment Product
    Table 65. AstraZeneca Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
    Table 66. AstraZeneca Recent Development
    Table 67. Eli Lilly Company Details
    Table 68. Eli Lilly Business Overview
    Table 69. Eli Lilly Sickle Cell Disease Treatment Product
    Table 70. Eli Lilly Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
    Table 71. Eli Lilly Recent Development
    Table 72. Novartis Company Details
    Table 73. Novartis Business Overview
    Table 74. Novartis Sickle Cell Disease Treatment Product
    Table 75. Novartis Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
    Table 76. Novartis Recent Development
    Table 77. Pfizer Company Details
    Table 78. Pfizer Business Overview
    Table 79. Pfizer Sickle Cell Disease Treatment Product
    Table 80. Pfizer Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
    Table 81. Pfizer Recent Development
    Table 82. Baxter Company Details
    Table 83. Baxter Business Overview
    Table 84. Baxter Sickle Cell Disease Treatment Product
    Table 85. Baxter Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
    Table 86. Baxter Recent Development
    Table 87. Emmaus Life Sciences Company Details
    Table 88. Emmaus Life Sciences Business Overview
    Table 89. Emmaus Life Sciences Sickle Cell Disease Treatment Product
    Table 90. Emmaus Life Sciences Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
    Table 91. Emmaus Life Sciences Recent Development
    Table 92. Bluebird bio Company Details
    Table 93. Bluebird bio Business Overview
    Table 94. Bluebird bio Sickle Cell Disease Treatment Product
    Table 95. Bluebird bio Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
    Table 96. Bluebird bio Recent Development
    Table 97. Blood Therapeutics Company Details
    Table 98. Blood Therapeutics Business Overview
    Table 99. Blood Therapeutics Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
    Table 100. Blood Therapeutics Recent Development
    Table 101. Sangamo Therapeutics Company Details
    Table 102. Sangamo Therapeutics Business Overview
    Table 103. Sangamo Therapeutics Sickle Cell Disease Treatment Product
    Table 104. Sangamo Therapeutics Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
    Table 105. Sangamo Therapeutics Recent Development
    Table 106. Acceleron Pharma Company Details
    Table 107. Acceleron Pharma Business Overview
    Table 108. Acceleron Pharma Sickle Cell Disease Treatment Product
    Table 109. Acceleron Pharma Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
    Table 110. Acceleron Pharma Recent Development
    Table 111. Arena Pharmaceuticals Company Details
    Table 112. Arena Pharmaceuticals Business Overview
    Table 113. Arena Pharmaceuticals Sickle Cell Disease Treatment Product
    Table 114. Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
    Table 115. Arena Pharmaceuticals Recent Development
    Table 116. Alnylam Pharmaceuticals Company Details
    Table 117. Alnylam Pharmaceuticals Business Overview
    Table 118. Alnylam Pharmaceuticals Sickle Cell Disease Treatment Product
    Table 119. Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
    Table 120. Alnylam Pharmaceuticals Recent Development
    Table 121. Sanofi Company Details
    Table 122. Sanofi Business Overview
    Table 123. Sanofi Sickle Cell Disease Treatment Product
    Table 124. Sanofi Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
    Table 125. Sanofi Recent Development
    Table 126. CRISPR Therapeutics Company Details
    Table 127. CRISPR Therapeutics Business Overview
    Table 128. CRISPR Therapeutics Sickle Cell Disease Treatment Product
    Table 129. CRISPR Therapeutics Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
    Table 130. CRISPR Therapeutics Recent Development
    Table 131. Vertex Pharmaceuticals, Inc. Company Details
    Table 132. Vertex Pharmaceuticals, Inc. Business Overview
    Table 133. Vertex Pharmaceuticals, Inc. Sickle Cell Disease Treatment Product
    Table 134. Vertex Pharmaceuticals, Inc. Revenue in Sickle Cell Disease Treatment Business (2016-2021) & (US$ Million)
    Table 135. Vertex Pharmaceuticals, Inc. Recent Development
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Sickle Cell Disease Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Sickle Cell Anemia Features
    Figure 3. Sickle Beta Thalassemia Features
    Figure 4. Sickle Hemoglobin C Disease Features
    Figure 5. Global Sickle Cell Disease Treatment Market Share by Application: 2020 VS 2027
    Figure 6. Hospitals Case Studies
    Figure 7. Clinics Case Studies
    Figure 8. Others Case Studies
    Figure 9. Sickle Cell Disease Treatment Report Years Considered
    Figure 10. Global Sickle Cell Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Sickle Cell Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Sickle Cell Disease Treatment Market Share by Regions: 2020 VS 2027
    Figure 13. Global Sickle Cell Disease Treatment Market Share by Regions (2022-2027)
    Figure 14. Global Sickle Cell Disease Treatment Market Share by Players in 2020
    Figure 15. Global Top Sickle Cell Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell Disease Treatment as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Sickle Cell Disease Treatment Revenue in 2020
    Figure 17. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2016-2021)
    Figure 18. Global Sickle Cell Disease Treatment Revenue Market Share by Type (2022-2027)
    Figure 19. North America Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Sickle Cell Disease Treatment Market Share by Type (2016-2027)
    Figure 21. North America Sickle Cell Disease Treatment Market Share by Application (2016-2027)
    Figure 22. North America Sickle Cell Disease Treatment Market Share by Country (2016-2027)
    Figure 23. United States Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Sickle Cell Disease Treatment Market Share by Type (2016-2027)
    Figure 27. Europe Sickle Cell Disease Treatment Market Share by Application (2016-2027)
    Figure 28. Europe Sickle Cell Disease Treatment Market Share by Country (2016-2027)
    Figure 29. Germany Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Sickle Cell Disease Treatment Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Sickle Cell Disease Treatment Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Sickle Cell Disease Treatment Market Share by Region (2016-2027)
    Figure 39. China Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Sickle Cell Disease Treatment Market Share by Type (2016-2027)
    Figure 47. Latin America Sickle Cell Disease Treatment Market Share by Application (2016-2027)
    Figure 48. Latin America Sickle Cell Disease Treatment Market Share by Country (2016-2027)
    Figure 49. Mexico Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Sickle Cell Disease Treatment Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Sickle Cell Disease Treatment Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Sickle Cell Disease Treatment Market Share by Country (2016-2027)
    Figure 55. Turkey Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Sickle Cell Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. AstraZeneca Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
    Figure 59. Eli Lilly Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
    Figure 60. Novartis Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
    Figure 61. Pfizer Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
    Figure 62. Baxter Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
    Figure 63. Emmaus Life Sciences Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
    Figure 64. Bluebird bio Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
    Figure 65. Blood Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
    Figure 66. Sangamo Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
    Figure 67. Acceleron Pharma Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
    Figure 68. Arena Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
    Figure 69. Alnylam Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
    Figure 70. Sanofi Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
    Figure 71. CRISPR Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
    Figure 72. Vertex Pharmaceuticals, Inc. Revenue Growth Rate in Sickle Cell Disease Treatment Business (2016-2021)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$5850
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$7800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

Global and Japan Sickle Cell Disease Treatment Market Size Status and Forecast 2021 2027
Global and Japan Sickle Cell Disease Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-5J6745
Sat Sep 04 00:00:00 UTC 2021

Add to Cart

Global and United States Gaucher Disease Drugs Market Insights Forecast to 2027
Global and United States Gaucher Disease Drugs Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-34P1517
Thu Aug 12 00:00:00 UTC 2021

Add to Cart

China Adrenoleukodystrophy Drugs Market Report Forecast 2021 2027
China Adrenoleukodystrophy Drugs Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-29S5308
Wed Aug 11 00:00:00 UTC 2021

Add to Cart

Global Phenylketonuria PKU Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
Global Phenylketonuria (PKU) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2021-2027

In 2020 the global Phenylketonuria PKU market size was US 1176 million and it is expected to reach US 2382.7 million by the end of 2027 with a CAGR of 10.2 during 20212027.Global Phenylketonuria PKU Market Size Manufacturers Supply Chain Sales Channel and Clients 20212027.

120 Pages
Type: Report
Code: QYRE-Auto-19N5243
Wed Aug 11 00:00:00 UTC 2021

Add to Cart